At Thobari, J, Damayanti, W, Haposan, JH, Nirwati, H, Iskandar, K, Samad, Fahmi, J, Sari, RM, Bachtiar, NS, Watts, E, et al.
Safety and immunogenicity of human neonatal RV3 rotavirus vaccine (Bio Farma) in adults, children, and neonates in Indonesia: Phase I Trial.
Vaccine
39(33)
:
4651 -4658
2021
view publication
Hamidi, A, Hoeksema, F, Velthof, P, Lemckert, A, Gillissen, G, Luitjens, A, Bines, JE, Pullagurla, SR, Kumar, P, Volkin, DB, et al.
Developing a manufacturing process to deliver a cost effective and stable liquid human rotavirus vaccine.
Vaccine
39(15)
:
2048 -2059
2021
view publication
Kumar, P, Pullagurla, SR, Patel, A, Shukla, RS, Bird, C, Kumru, OS, Hamidi, A, Hoeksema, F, Yallop, C, Bines, JE, et al.
Effect of Formulation Variables on the Stability of a Live, Rotavirus (RV3-BB) Vaccine Candidate using in vitro Gastric Digestion Models to Mimic Oral Delivery.
Journal of Pharmaceutical Sciences
110(2)
:
760 -770
2021
view publication
Jenney, AWJ, Reyburn, R, Ratu, FT, Tuivaga, E, Nguyen, C, Covea, S, Thomas, S, Rafai, E, Devi, R, Bright, K, et al.
The impact of the rotavirus vaccine on diarrhoea, five years following national introduction in Fiji.
The Lancet Regional Health - Western Pacific
6:
100053
2021
view publication
Witte, D, Handley, A, Jere, KC, Bogandovic-Sakran, N, Mpakiza, A, Turner, A, Pavlic, D, Boniface, K, Mandolo, J, Ong, DS, et al.
Neonatal Rotavirus Vaccine (RV3-BB) Immunogenicity and Safety in a Neonatal and Infant Administration Schedule in Malawi: A Randomized, Double-Blind, Four-Arm Parallel Group Dose-Ranging Study.
2021
view publication